BioSpace News Archive

Business

Cystic Fibrosis Foundation Announces Steven Rowe, MD, as Next Chief Scientific Officer

Dr. Steven Rowe will support mission to cure cystic fibrosis by leading the Foundation’s research strategy, focusing on genetic therapies.

January 26, 2022
·
3 min read
Biotech Bay

Cortexyme Announces Clinical Hold on Atuzaginstat’s Investigational New Drug Application

Cortexyme Announces Clinical Hold on Atuzaginstat’s Investigational New Drug Application.

January 26, 2022
·
4 min read
Business

Veru to Report Fiscal 2022 First-Quarter Financial Results, Host Conference Call on February 9th

Veru Inc. today announced that it will report financial results for its fiscal 2022 first quarter, on Wednesday, February 9, 2022, before the market opens.

January 26, 2022
·
7 min read
Quotient Limited Launches Scientific Advisory Board and Research Programs

Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company headquartered in Eysins, Switzerland, today provided a Scientific Advisory Board and Research Program update.

January 26, 2022
·
4 min read
Business

Surmodics to Webcast First Quarter Fiscal 2022 Earnings Conference Call on February 3

Surmodics, Inc. today announced that it will host a live webcast of its first quarter fiscal 2022 conference call on Thursday, February 3, at 7:30 a.m. CT (8:30 a.m. ET).

January 26, 2022
·
2 min read
BioMidwest

Dynamic Technology Solutions Introduces Self-Diagnostic Tool that Measures Product End-of-Life (EOL) Risk Exposure

Dynamic Technology Solutions (Dynamic) announced today the introduction of its EOL PrepSM Self-Diagnostic, based on industry best practices, that provides insights into how well a company is managing risks associated with product End-of-Life (EOL).

January 26, 2022
·
2 min read
Business

ADHEREHEALTH AND LEVRX TECHNOLOGY ANNOUNCE STRATEGIC PARTNERSHIP TO IMPROVE MEDICATION OPTIMIZATION AND REDUCE PHARMACY COSTS

AdhereHealth, a healthcare technology leader in medication adherence insights and health outcomes, today announced a new integration partnership with Levrx Technology Inc, a digital health technology company that drives prescription efficiencies and maximizes savings.

January 26, 2022
·
4 min read
Business

AccurKardia Announces Collaboration with MDF Instruments to Develop ECG Solutions for the Next Generation of Stethoscopes

AccurKardia, Inc., a software company that provides clinical-grade, device agnostic, automated ECG analytics, today announced a collaboration with MDF Instruments, a highly-regarded and longstanding medical supplier, to develop ECG (electrocardiogram) solutions for the next generation of stethoscopes.

January 26, 2022
·
3 min read
Business

Senda Biosciences Appoints Stuart Milstein, Ph.D., as SVP and Head of Platform Biology

Senda Biosciences, Inc., a company that is harnessing nature to program targeted, potent and tunable medicines, has appointed Stuart Milstein, Ph.D., to the newly created position of Senior Vice President and Head of Platform Biology.

January 26, 2022
·
5 min read
Zhittya Genesis Medicine-Parkinson’s Disease-Free Webinar for its Clinical Trial to treat Parkinson’s Disease

Zhittya Genesis Medicine, Inc. (a private company) (“Zhittya”), announced that it is starting a “Compassionate Use Clinical Trial” for treatment of Parkinson’s disease.

January 26, 2022
·
4 min read